Cell Marque™ 一級抗體

相關資源

• Article: Immunohistochemistry: Current Applications in Breast Cancer

  Immunohistochemistry (IHC) characterizes proteins in tissues, aiding in tumor subtype identification, tissue origin confirmation, and prognosis assessment.

• Brochure: A Comparative Study of IDH1 R132H

  IDH1 R132H mutation aids in distinguishing gliomas and glioblastomas. A study compared two monoclonal antibodies for detecting this mutation.

• Brochure: Immuno Histo Chemistry

  Cell Marque™ products join the Sigma-Aldrich^® portfolio, enhancing tissue diagnostics. Volume 12 of the Reference Guide emphasizes IHC antibodies for clinical diagnostics.

• Brochure: Immunohistochemical Applications in Dermatopathology

  Despite advances in immunohistochemistry, dermatopathology still relies on H&E stains. IHC can aid pathologists in detecting challenging cases.

• Brochure: Pediatric Malignancies and IHC

  Pediatric tumors, especially "small round blue cell tumors," are diverse and challenging to detect. Effective diagnosis requires focused immunohistochemistry and comprehensive testing.

• Brochure: Anti-Ki-67 (MRQ-64) is a Reliable Rabbit Monoclonal IHC Marker

  The Ki-67 antigen indicates cell proliferation and is used for grading various neoplasms. A study compared the novel MRQ-64 antibody to other clones using IHC on diverse tissues.

• Brochure: Special AT-rich sequence binding-protein 2 (SATB2)

  Cancers of unknown primary (CUP) make up 3-5% of cases, often adenocarcinomas. IHC aids in diagnosis, but over 80% remain unidentified. Key antibodies include CK20, CDX-2, and SATB2 for colorectal and GI tract carcinomas.